In conclusion, the analysis of results demonstrates a clear increase in TNF-α and a decrease in CCL18 secretion by blood-derived monocytes from T2DM patients with diabetic foot syndrome in relation to carbohydrate metabolism status (compensated/decompensated) and the severity of ischemia. This evidence concerns the gene TNF and type 2 diabetes mellitus.